Literature DB >> 33137520

Prostaglandin and prostamide concentrations in amniotic fluid of women with spontaneous labor at term with and without clinical chorioamnionitis.

Hassendrini N Peiris1, Roberto Romero2, Kanchan Vaswani1, Nardhy Gomez-Lopez3, Adi L Tarca4, Dereje W Gudicha5, Offer Erez6, Eli Maymon7, Sarah Reed8, Murray D Mitchell9.   

Abstract

OBJECTIVE: Prostaglandins (PGs) are considered universal mediators for the process of physiological parturition. This is based on observations that amniotic fluid concentrations of PGs are elevated prior to and during the onset of labor (mostly utilizing immunoassays). Distinguishing PGs from similarly structured molecules (i.e. prostamides; PG-EA) is difficult given the cross-reactivity of available antibodies and the chemical similarity between these compounds. Herein, this limitation was overcome by utilizing mass spectrometry to determine PG and PG-EA concentrations in amniotic fluid of women with spontaneous labor at term and in those with clinical chorioamnionitis (CHAM), the most common infection-related diagnosis made in labor and delivery units worldwide. STUDY
DESIGN: Liquid chromatography-tandem mass spectrometry (LC MS/MS) was used to determine the PG and PG-EA content in amniotic fluid samples of women with spontaneous labor at term with (n = 14) or without (n = 28) CHAM. Controls included women who delivered at term without labor (n = 10).
RESULTS: PGE2, PGF2α, and 13,14-dihydro-15-keto-PGF2α (PGFM) were higher in amniotic fluid of women with spontaneous labor at term than in those without labor. PGE2, PGF2α, and PGFM were also higher in amniotic fluid of women with CHAM than in those without labor. However, PGE2-EA and PGF2α-EA were lower in amniotic fluid of women with CHAM than in those without CHAM. The ratios of PGE2 to PGE2-EA and PGF2α to PGF2α-EA were higher in amniotic fluid of women with spontaneous labor at term with or without CHAM than in those without labor; yet, the ratio of PGF2α to PGF2α-EA was greater in women with CHAM than in those without this clinical condition.
CONCLUSIONS: Spontaneous labor at term with or without CHAM is characterized by elevated amniotic fluid concentrations of prostaglandins (PGE2, PGF2α, and PGFM) but not prostamides. Quantification of these products by LC MS/MSlc==may potentially be of utility in identifying their physiological functions relevant to parturition.
SUMMARY: Prostaglandins (PGs) are critical for the onset and progression of labor. Structural similarities of PGs and prostamides (PG-EA) prevents their specific identification by immunoassay. We utilized LC MS/MS to determine PG and PG-EA content in amniotic fluid (AF) of women with spontaneous labor at term with or without CHAM and women who delivered at term without labor. Higher aamniotic ffluid PG levels were observed in women with spontaneous labor with and without CHAM compared to women delivering without labor. PG-EA levels in amniotic fluid of women with spontaneous labor and CHAM were lower than in women with spontaneous labor without CHAM but not those without labor. Ratios of PGs to PG-EAs were higher in AF of women with labor and CHAM compared to those without labor. Delineation of these products by LC MS/MS may potentially be of utility in identifying their physiological functions relevant to parturition.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Eicosanoids; Intra-amniotic infection; Lipid mediators; Mass spectrometry; Parturition; Pregnancy; Prostaglandins

Mesh:

Substances:

Year:  2020        PMID: 33137520      PMCID: PMC8314956          DOI: 10.1016/j.plefa.2020.102195

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  66 in total

1.  Microbial invasion of the amniotic cavity in pregnancies with small-for-gestational-age fetuses.

Authors:  Daniel B DiGiulio; Maria Teresa Gervasi; Roberto Romero; Edi Vaisbuch; Shali Mazaki-Tovi; Juan Pedro Kusanovic; Kimberley S Seok; Ricardo Gómez; Pooja Mittal; Francesca Gotsch; Tinnakorn Chaiworapongsa; Enrique Oyarzún; Chong Jai Kim; David A Relman
Journal:  J Perinat Med       Date:  2010-09       Impact factor: 1.901

2.  Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes.

Authors:  M Maccarrone; L De Petrocellis; M Bari; F Fezza; S Salvati; V Di Marzo; A Finazzi-Agrò
Journal:  Arch Biochem Biophys       Date:  2001-09-15       Impact factor: 4.013

Review 3.  Chorioamnionitis and intraamniotic infection.

Authors:  E R Newton
Journal:  Clin Obstet Gynecol       Date:  1993-12       Impact factor: 2.190

Review 4.  Acute chorioamnionitis.

Authors:  L C Gilstrap; S M Cox
Journal:  Obstet Gynecol Clin North Am       Date:  1989-06       Impact factor: 2.844

5.  Clinical chorioamnionitis at term: the amniotic fluid fatty acyl lipidome.

Authors:  Krishna Rao Maddipati; Roberto Romero; Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Sen-Lin Zhou; Zhonghui Xu; Adi L Tarca; Juan Pedro Kusanovic; Ricardo Gomez; Nikolina Docheva; Kenneth V Honn
Journal:  J Lipid Res       Date:  2016-08-18       Impact factor: 5.922

6.  Amniotic fluid glucose concentration: a rapid and simple method for the detection of intraamniotic infection in preterm labor.

Authors:  R Romero; C Jimenez; A K Lohda; J Nores; S Hanaoka; C Avila; R Callahan; M Mazor; J C Hobbins; M P Diamond
Journal:  Am J Obstet Gynecol       Date:  1990-09       Impact factor: 8.661

7.  Increase in prostaglandin bioavailability precedes the onset of human parturition.

Authors:  R Romero; H Munoz; R Gomez; M Parra; M Polanco; V Valverde; J Hasbun; J Garrido; F Ghezzi; M Mazor; J E Tolosa; M D Mitchell
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1996-03       Impact factor: 4.006

8.  Amniotic fluid eicosanoids in preterm and term births: effects of risk factors for spontaneous preterm labor.

Authors:  Ramkumar Menon; Stephen J Fortunato; Ginger L Milne; Lina Brou; Claudine Carnevale; Stephanie C Sanchez; Leah Hubbard; Martha Lappas; Cayce Owens Drobek; Robert N Taylor
Journal:  Obstet Gynecol       Date:  2011-07       Impact factor: 7.661

9.  Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock.

Authors:  J A Wagner; K Varga; E F Ellis; B A Rzigalinski; B R Martin; G Kunos
Journal:  Nature       Date:  1997-12-04       Impact factor: 49.962

10.  Clinical chorioamnionitis is characterized by changes in the expression of the alarmin HMGB1 and one of its receptors, sRAGE.

Authors:  Roberto Romero; Tinnakorn Chaiworapongsa; Zeynep Alpay Savasan; Youssef Hussein; Zhong Dong; Juan Pedro Kusanovic; Chong Jai Kim; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2012-06
View more
  4 in total

Review 1.  The immunobiology of preterm labor and birth: intra-amniotic inflammation or breakdown of maternal-fetal homeostasis.

Authors:  Nardhy Gomez-Lopez; Jose Galaz; Derek Miller; Marcelo Farias-Jofre; Zhenjie Liu; Marcia Arenas-Hernandez; Valeria Garcia-Flores; Zachary Shaffer; Jonathan M Greenberg; Kevin R Theis; Roberto Romero
Journal:  Reproduction       Date:  2022-06-20       Impact factor: 3.923

2.  Prostaglandins in biofluids in pregnancy and labour: A systematic review.

Authors:  Eilidh M Wood; Kylie K Hornaday; Donna M Slater
Journal:  PLoS One       Date:  2021-11-18       Impact factor: 3.240

Review 3.  The Role of Innate Immune System in the Human Amniotic Membrane and Human Amniotic Fluid in Protection Against Intra-Amniotic Infections and Inflammation.

Authors:  Tina Šket; Taja Železnik Ramuta; Marjanca Starčič Erjavec; Mateja Erdani Kreft
Journal:  Front Immunol       Date:  2021-10-21       Impact factor: 7.561

4.  Clinical characteristics of colonization of the amniotic cavity in women with preterm prelabor rupture of membranes, a retrospective study.

Authors:  Marian Kacerovsky; Jaroslav Stranik; Jana Matulova; Martina Chalupska; Jan Mls; Tomáš Faist; Helena Hornychova; Rudolf Kukla; Radka Bolehovska; Pavel Bostik; Bo Jacobsson; Ivana Musilova
Journal:  Sci Rep       Date:  2022-03-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.